"Myocardial Ischemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Descriptor ID |
D017202
|
| MeSH Number(s) |
C14.280.647 C14.907.585
|
| Concept/Terms |
Myocardial Ischemia- Myocardial Ischemia
- Ischemia, Myocardial
- Ischemias, Myocardial
- Myocardial Ischemias
- Ischemic Heart Disease
- Heart Disease, Ischemic
- Disease, Ischemic Heart
- Diseases, Ischemic Heart
- Heart Diseases, Ischemic
- Ischemic Heart Diseases
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Ischemia".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Ischemia".
This graph shows the total number of publications written about "Myocardial Ischemia" by people in this website by year, and whether "Myocardial Ischemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocardial Ischemia" by people in Profiles.
-
Perivascular Adipose Tissue Inflammation in Ischemic Heart Disease. Arterioscler Thromb Vasc Biol. 2021 03; 41(3):1239-1250.
-
New Applications in Echocardiography for Ultrasound Contrast Agents in the 21st Century. Ultrasound Med Biol. 2020 05; 46(5):1071-1081.
-
Nutrition, risk factors, prevention, and imaging: The 2018 Mario Verani Lecture. J Nucl Cardiol. 2019 Feb; 26(1):86-91.
-
Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging. J Nucl Cardiol. 2020 10; 27(5):1521-1532.
-
Exercise Hemodynamic and Functional Capacity After Mitral Valve Replacement in Patients With Ischemic Mitral Regurgitation: A Comparison of Mechanical Versus Biological Prostheses. Circ Heart Fail. 2018 01; 11(1):e004056.
-
Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging? Trends Cardiovasc Med. 2018 01; 28(1):24-37.
-
Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA? catheter mapping. Cardiovasc Revasc Med. 2018 12; 19(8S):50-52.
-
Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease. Am J Health Syst Pharm. 2015 Oct 01; 72(19):1615-22.
-
The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol. 2015 Jun; 22(3):526-34.
-
Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015 Jun; 149(6):1595-603.